Rafferty Asset Management
ZOM

Rafferty Asset Management’s Zomedica Corp. ZOM Stock Holding History

Rafferty Asset Management’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-531,861
Closed -$443K – 1336
2021
Q2 		$443K Buy
531,861
+364,795
+218% +$340K ﹤0.01% 1095
2021
Q1 		$264K Buy
+167,066
New +$273K ﹤0.01% 1107

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rafferty Asset Management's ZOM Position: Q3 2021 in Review

Rafferty Asset Management sold out of Zomedica Corp. (ZOM) in Q3 2021, closing a stake of 531,861 shares — an estimated $443K sold.

Rafferty Asset Management first reported a position in ZOM in Q1 2021 and held it in 2 quarters. The position peaked at $443K in Q2 2021. 107 funds tracked by Wall St. Rank hold ZOM as of Q3 2021.

  • Rafferty Asset Management reported no remaining Zomedica Corp. position as of Q3 2021 after selling out during the quarter.
  • Rafferty Asset Management sold 531,861 Zomedica Corp. shares in Q3 2021, an estimated $443K.
  • Rafferty Asset Management first reported a position in Zomedica Corp. in Q1 2021 and held it in 2 quarters.
  • Rafferty Asset Management's Zomedica Corp. position peaked at $443K in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2021.

Based on Rafferty Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.